Induction of Endogenous Antibody Recruitment to the Surface of the Pathogen Enterococcus faecium.
Ontology highlight
ABSTRACT: For the foreseeable future, conventional small molecule antibiotics will continue to be the predominant treatment option due to wide patient coverage and low costs. Today, however, there is already a significant portion of patients that fail to respond to small molecule antibiotics and, according to the Centers for Disease Control and Prevention, this number is poised to increase in the coming years. Therefore, this rise in drug resistant bacteria must be countered with the development of nontraditional therapies. We propose a measure based on the re-engagement of the immune system toward pathogenic bacteria by grafting bacterial cell surfaces with immunogenic agents. Herein, we describe a class of cell wall analogues that selectively graft bacterial cell surfaces with epitopes that promot
SUBMITTER: Dalesandro BE
PROVIDER: S-EPMC8415127 | biostudies-literature | 2021 May
REPOSITORIES: biostudies-literature
ACCESS DATA